Showing 66,021 - 66,040 results of 104,217 for search '(( 5 ((((we decrease) OR (a decrease))) OR (mean decrease)) ) OR ( 2 step decrease ))', query time: 2.00s Refine Results
  1. 66021

    Intravenous MSC treatment prevented white matter injury and reduced electrographic seizure activity after global HI. by Reint K. Jellema (127097)

    Published 2013
    “…(<b>B</b>) Global HI caused a significant decrease in FA values in the SCWM, which was prevented by intravenous MSC administration; means ± 95% CI and levels of significance are depicted, which were calculated with ANOVA (sham-SAL n=8, sham-MSC n=4, HI-SAL n=8, HI-MSC n=8). …”
  2. 66022

    Germination and biochemical changes in West Indian gherkin seeds under water stress at different temperatures by João Paulo Nobre de Almeida (4659739)

    Published 2019
    “…The experimental design was completely randomized, in 5 x 5 factorial scheme, composed of five osmotic potentials (0.0; -0.1; -0.2; -0.3 and -0.4 MPa) and four temperatures (20; 25; 30 °C and alternating temperatures of 20-30 ºC), with each treatment composed of four replicates of 50 seeds. …”
  3. 66023

    The funnel plot of visual analog scale score. by Guimei Guo (4127074)

    Published 2024
    “…The change in visual analog scale (VAS) score 3 months post intervention (MD = -0.33, 95% Cl: -0.52 to -0.13, P = 0.001), 6 months (MD = -0.69, 95% Cl: -0.90 to -0.48, P < 0.00001), 12 months (MD = -0.75, 95% Cl: -1.05 to -0.46, P < 0.00001), ≥ 24 months (MD = -1.05, 95% Cl: -1.20 to -0.89, P < 0.00001), and the last follow-up (MD = -0.75, 95% Cl: -0.97 to -0.54, P < 0.00001). The PRP also showed a decrease in VAS score compared to baseline than the non-PRP at 3 months (MD = -0.29, 95% Cl: -0.41 to -0.17, P = 0.003), 6 months (MD = -0.63, 95% Cl: -0.96 to -0.30, P = 0.0002), 12 months (MD = -0.78, 95% Cl: -1.22 to -0.33, P = 0.0006), ≥ 24 months (MD = -1.11, 95% Cl: -1.27 to -0.96, P < 0.00001), and the last follow-up (MD = -0.74, 95% Cl: -1.05 to -0.43, P < 0.00001). …”
  4. 66024

    Intervention characteristics of included studies. by Guimei Guo (4127074)

    Published 2024
    “…The change in visual analog scale (VAS) score 3 months post intervention (MD = -0.33, 95% Cl: -0.52 to -0.13, P = 0.001), 6 months (MD = -0.69, 95% Cl: -0.90 to -0.48, P < 0.00001), 12 months (MD = -0.75, 95% Cl: -1.05 to -0.46, P < 0.00001), ≥ 24 months (MD = -1.05, 95% Cl: -1.20 to -0.89, P < 0.00001), and the last follow-up (MD = -0.75, 95% Cl: -0.97 to -0.54, P < 0.00001). The PRP also showed a decrease in VAS score compared to baseline than the non-PRP at 3 months (MD = -0.29, 95% Cl: -0.41 to -0.17, P = 0.003), 6 months (MD = -0.63, 95% Cl: -0.96 to -0.30, P = 0.0002), 12 months (MD = -0.78, 95% Cl: -1.22 to -0.33, P = 0.0006), ≥ 24 months (MD = -1.11, 95% Cl: -1.27 to -0.96, P < 0.00001), and the last follow-up (MD = -0.74, 95% Cl: -1.05 to -0.43, P < 0.00001). …”
  5. 66025

    GRADE evaluation of evidence quality. by Guimei Guo (4127074)

    Published 2024
    “…The change in visual analog scale (VAS) score 3 months post intervention (MD = -0.33, 95% Cl: -0.52 to -0.13, P = 0.001), 6 months (MD = -0.69, 95% Cl: -0.90 to -0.48, P < 0.00001), 12 months (MD = -0.75, 95% Cl: -1.05 to -0.46, P < 0.00001), ≥ 24 months (MD = -1.05, 95% Cl: -1.20 to -0.89, P < 0.00001), and the last follow-up (MD = -0.75, 95% Cl: -0.97 to -0.54, P < 0.00001). The PRP also showed a decrease in VAS score compared to baseline than the non-PRP at 3 months (MD = -0.29, 95% Cl: -0.41 to -0.17, P = 0.003), 6 months (MD = -0.63, 95% Cl: -0.96 to -0.30, P = 0.0002), 12 months (MD = -0.78, 95% Cl: -1.22 to -0.33, P = 0.0006), ≥ 24 months (MD = -1.11, 95% Cl: -1.27 to -0.96, P < 0.00001), and the last follow-up (MD = -0.74, 95% Cl: -1.05 to -0.43, P < 0.00001). …”
  6. 66026

    PRISMA flow diagram. by Guimei Guo (4127074)

    Published 2024
    “…The change in visual analog scale (VAS) score 3 months post intervention (MD = -0.33, 95% Cl: -0.52 to -0.13, P = 0.001), 6 months (MD = -0.69, 95% Cl: -0.90 to -0.48, P < 0.00001), 12 months (MD = -0.75, 95% Cl: -1.05 to -0.46, P < 0.00001), ≥ 24 months (MD = -1.05, 95% Cl: -1.20 to -0.89, P < 0.00001), and the last follow-up (MD = -0.75, 95% Cl: -0.97 to -0.54, P < 0.00001). The PRP also showed a decrease in VAS score compared to baseline than the non-PRP at 3 months (MD = -0.29, 95% Cl: -0.41 to -0.17, P = 0.003), 6 months (MD = -0.63, 95% Cl: -0.96 to -0.30, P = 0.0002), 12 months (MD = -0.78, 95% Cl: -1.22 to -0.33, P = 0.0006), ≥ 24 months (MD = -1.11, 95% Cl: -1.27 to -0.96, P < 0.00001), and the last follow-up (MD = -0.74, 95% Cl: -1.05 to -0.43, P < 0.00001). …”
  7. 66027

    Summary data and analyses. by Guimei Guo (4127074)

    Published 2024
    “…The change in visual analog scale (VAS) score 3 months post intervention (MD = -0.33, 95% Cl: -0.52 to -0.13, P = 0.001), 6 months (MD = -0.69, 95% Cl: -0.90 to -0.48, P < 0.00001), 12 months (MD = -0.75, 95% Cl: -1.05 to -0.46, P < 0.00001), ≥ 24 months (MD = -1.05, 95% Cl: -1.20 to -0.89, P < 0.00001), and the last follow-up (MD = -0.75, 95% Cl: -0.97 to -0.54, P < 0.00001). The PRP also showed a decrease in VAS score compared to baseline than the non-PRP at 3 months (MD = -0.29, 95% Cl: -0.41 to -0.17, P = 0.003), 6 months (MD = -0.63, 95% Cl: -0.96 to -0.30, P = 0.0002), 12 months (MD = -0.78, 95% Cl: -1.22 to -0.33, P = 0.0006), ≥ 24 months (MD = -1.11, 95% Cl: -1.27 to -0.96, P < 0.00001), and the last follow-up (MD = -0.74, 95% Cl: -1.05 to -0.43, P < 0.00001). …”
  8. 66028

    The funnel plot of Harris hip score. by Guimei Guo (4127074)

    Published 2024
    “…The change in visual analog scale (VAS) score 3 months post intervention (MD = -0.33, 95% Cl: -0.52 to -0.13, P = 0.001), 6 months (MD = -0.69, 95% Cl: -0.90 to -0.48, P < 0.00001), 12 months (MD = -0.75, 95% Cl: -1.05 to -0.46, P < 0.00001), ≥ 24 months (MD = -1.05, 95% Cl: -1.20 to -0.89, P < 0.00001), and the last follow-up (MD = -0.75, 95% Cl: -0.97 to -0.54, P < 0.00001). The PRP also showed a decrease in VAS score compared to baseline than the non-PRP at 3 months (MD = -0.29, 95% Cl: -0.41 to -0.17, P = 0.003), 6 months (MD = -0.63, 95% Cl: -0.96 to -0.30, P = 0.0002), 12 months (MD = -0.78, 95% Cl: -1.22 to -0.33, P = 0.0006), ≥ 24 months (MD = -1.11, 95% Cl: -1.27 to -0.96, P < 0.00001), and the last follow-up (MD = -0.74, 95% Cl: -1.05 to -0.43, P < 0.00001). …”
  9. 66029

    Binarized cross recurrence plot of the MT-M1 functional connectivity. by Clara Rodriguez-Sabate (4512394)

    Published 2021
    “…The PD group shows a decrease of the ON-ON match density in both the resting-task block (Fig 5B) and the motor-task block (Fig 5D).…”
  10. 66030

    Highly Porous, Hydrophobic, and Compressible Cellulose Nanocrystals/Poly(vinyl alcohol) Aerogels as Recyclable Absorbents for Oil–Water Separation by Xiaoyu Gong (2284477)

    Published 2019
    “…With the three-dimensional interconnected microstructure, the aerogels were highly porous (porosity >97.7%) and ultralight with a density ranging from 22.5 to 36.1 mg/cm<sup>3</sup> and floatable on the water surface. …”
  11. 66031

    Highly Porous, Hydrophobic, and Compressible Cellulose Nanocrystals/Poly(vinyl alcohol) Aerogels as Recyclable Absorbents for Oil–Water Separation by Xiaoyu Gong (2284477)

    Published 2019
    “…With the three-dimensional interconnected microstructure, the aerogels were highly porous (porosity >97.7%) and ultralight with a density ranging from 22.5 to 36.1 mg/cm<sup>3</sup> and floatable on the water surface. …”
  12. 66032

    AAV-BDNF counteracts thoraco-lumbar BDNF deficits and causes BDNF overproduction in spinal segments 7 weeks after spinal cord transection. by Ewelina Ziemlińska (420612)

    Published 2014
    “…Spinal cord transection leads to a decrease in the BDNF mRNA level (<b>B</b>; hatched bars) and protein concentration (<b>D</b>; hatched bars) in the lesion site, low thoracic and rostral lumbar segments. …”
  13. 66033

    The <i>I</i><sub>K1</sub>/Kir2.1 channel agonist zacopride prevents and cures acute ischemic arrhythmias in the rat by Xu-Wen Zhai (4033601)

    Published 2017
    “…However, clinical anti-arrhythmic agents that primarily act on RMP by enhancing the <i>I</i><sub>K1</sub> channel are not currently available. We hypothesized that zacopride, a selective and moderate agonist of the <i>I</i><sub>K1</sub>/Kir2.1 channels, prevents and cures acute ischemic arrhythmias. …”
  14. 66034

    Image_1_Optimizing estradiol level for gonadotrophin-releasing hormone antagonist initiation among patients with simple tubal factor infertility.jpg by Yizhuo Wang (5132726)

    Published 2022
    “…Through smooth curve fitting, we found that, with the increase of serum E<sub>2</sub> levels on the day of GnRH-ant initiation, CPR showed a trend of slight increase and then slight decrease. …”
  15. 66035

    IPF fibroblasts are desensitized to collagen rich matrix induced cell death in the presence of 3MA or CQ. by Richard Seonghun Nho (54078)

    Published 2014
    “…All assays were performed in three separate experiments to measure fibroblast viability or their proliferation using IPF cells in lane 5 and control fibroblasts in lane 3 in an upper panel in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0094616#pone-0094616-g001" target="_blank">Fig 1A</a>.…”
  16. 66036

    Circulating Endothelial Progenitor Cells in Kidney Transplant Patients by Giovana S. Di Marco (206524)

    Published 2011
    “…Indeed, multivariate analysis showed that SDF-1 – a cytokine responsible for EPC mobilization – is independently associated with the EPC number. 5/6 rats presented decreased EPC counts in comparison to control animals. …”
  17. 66037

    Low electro-synthesis potentials improve permselectivity of polymerized natural phenols in biosensor applications by Monti, Patrizia

    Published 2017
    “…Polymers were obtained by means of constant potential amperometry, instead of cyclic voltammetry, in order to achieve multiple polymerizations, hence decreasing the time of realization and variability. …”
    Get full text
    Get full text
    Get full text
  18. 66038

    DataSheet1_Long-Term Variation in Wintertime Atmospheric Diffusion Conditions Over the Sichuan Basin.docx by Guoyin Wang (10939987)

    Published 2021
    “…Both V<sub>E</sub> and ASI reveal a decrease tendency of atmospheric diffusion condition from the northwestern portion of the basin to the southeast. …”
  19. 66039

    Distinct CLP migratory groups persist under low serum conditions. by Joël Beyeler (652358)

    Published 2014
    “…<p>The graphs show the RWC in scratch wound assays at 24 h in 0.3% FCS/DMEM (*p<0.05, **p<0.01, ***p<0.001). (A) Despite a general decrease of the RWC, “fast” and “intermediate” CLP groups could still be distinguished under low-serum conditions. …”
  20. 66040

    Data_Sheet_1_Little Impact of NaCl Reduction in Swiss-Type Cheese.docx by Valérie Gagnaire (783586)

    Published 2022
    “…Casein hydrolysis in vitro was similar or higher at pH 5.2, i.e., cheese pH, compared to pH 7.5, and slightly decreased at the highest salt concentrations (3.0 and 4.4%). …”